Welcome to our dedicated page for Bleichroeder Acquisition II-A SEC filings (Ticker: BBCQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bleichroeder Acquisition Corp. II filings document the company’s SPAC structure, Nasdaq-listed securities, material-event reports, governance changes, and capital-structure disclosures. The records identify the issuer as a Cayman Islands exempted company with Class A ordinary shares under BBCQ and redeemable warrants under BBCQW.
The company’s 8-K disclosures include board and management changes, director appointments, and other material-event reporting. Its filings also state emerging growth company status and describe the warrant terms and ordinary-share structure that define the public securities associated with the blank-check issuer.
Bleichroeder Acquisition Corp. II reported leadership changes approved by its Board. Effective April 29, 2026, Andrew Gundlach resigned as President and Chief Executive Officer and was appointed Executive Chairman of the Board. Marcello Padula, previously Chief Operating Officer, was appointed Chief Executive Officer on the same date.
The company states there are no special arrangements or understandings behind these appointments, no family relationships with other executives or directors, and no related-party transactions requiring disclosure under Regulation S-K Item 404(a). Existing compensatory arrangements for both Mr. Gundlach and Mr. Padula remain unchanged.
Bleichroeder Acquisition 2 France II filed a communication that republishes an April 29, 2026 LinkedIn post by Wasiq Bokhari, Executive Chairman and CEO of Pasqal Holding SAS, discussing a Wall Street Journal interview about quantum computing and industry opportunity. The filing reiterates standard forward-looking statements cautioning that the proposed business combination between Bleichroeder and Pasqal is subject to risks and uncertainties.
The filing states Bleichroeder intends to file a Registration Statement on Form F-4 to serve as the proxy statement/prospectus for shareholder consideration and that the business combination will be submitted for a shareholder vote; additional details will be provided in the Registration Statement and definitive proxy statement/prospectus when available.
Bleichroeder Acquisition 2 France II (File No. 001-43045) distributed a communication highlighting The Wall Street Journal coverage of rising public-market interest in pure-play quantum companies and noting Pasqal among firms planning public listings. The communication discusses the proposed business combination between Bleichroeder and Pasqal and states that a Registration Statement on Form F-4 will be filed; the transaction will be submitted to Bleichroeder shareholders for approval.
The release contains standard forward-looking statements language listing risks such as shareholder redemptions, regulatory approvals, financing needs, and commercialization uncertainty, and directs investors to review the Registration Statement and the forthcoming definitive proxy statement/prospectus when available.
Bleichroeder Acquisition 2 France filed a communication announcing that Pasqal secured a European grant to lead the CoPaNA project. The initiative is a €4 million program over three years, selected under the European Defence Fund, to develop concatenated parity codes on neutral-atom processors with ParityQC and Thales.
The grant is described as defence‑relevant research toward fault‑tolerant, scalable quantum computing; the communication also reiterates customary forward‑looking statement disclosures tied to the pending business combination and upcoming Form F-4 registration process.
Bleichroeder Acquisition 2 France II discusses the growing wave of pure-play quantum computing companies entering public markets and notes Pasqal’s planned business combination with Bleichroeder. The communication describes SPACs as a faster route to public markets and lists multiple quantum firms that recently went public or expect to do so in 2026.
The filing identifies forward-looking statements about the proposed business combination with Pasqal, the plan to file a registration statement on Form F-4, and the requirement for shareholder and regulatory approvals. It directs investors to review the Registration Statement and proxy materials when available.
Bleichroeder Acquisition 2 France II disclosed a proposed business combination with Pasqal Holding SAS, describing how a public listing would support Pasqal's scaling and global ambitions. The communication explains that a Registration Statement on Form F-4 will be filed and that a definitive proxy statement/prospectus will be mailed after the Registration Statement is declared effective.
Bleichroeder Acquisition 2 France II posted a communication describing the proposed business combination with Pasqal Holding SAS and highlighted a Barron’s article on quantum companies going public. The notice states that Bleichroeder intends to file a Form F-4 (registration statement/proxy statement-prospectus) in connection with the shareholder vote and related securities issuances. The communication contains extensive forward-looking statements and a non-exhaustive list of risks tied to consummation, financing, regulatory approvals, shareholder redemptions, commercialization, and operational execution. It reminds readers that the definitive proxy statement/prospectus will be mailed after the Registration Statement is declared effective and directs investors to obtain copies from the SEC.
Bleichroeder Acquisition 2 France II proposes a business combination with Pasqal Holding SAS and intends to file a registration statement on Form F-4 to serve as the proxy statement/prospectus for the vote and the securities to be issued in the transaction.
The communication emphasizes that the combination is subject to shareholder and regulatory approvals and contains extensive forward-looking statements describing risks including redemptions, financing, regulatory approvals, and commercialization challenges; investors are directed to review the forthcoming Registration Statement and definitive proxy/prospectus available at www.sec.gov.
Bleichroeder Acquisition Corp. II and Pasqal Holding SAS disclosed plans for a business combination and capital raise to support Pasqal’s commercialization of neutral-atom quantum computers. The presentation highlights €340M in new funding, planned Nasdaq listing in H2 2026, enterprise QPU deployments, and manufacturing scale-up to expand cloud access and vertical use cases.
The CEO described seven operational high‑qubit QPUs, three more in production, partnerships with cloud and HPC providers, and a roadmap toward fault‑tolerant quantum computing (phase transition toward 2030+).
Bleichroeder Acquisition Corp. II reports that Bleichroeder Sponsor 2 LLC and affiliated reporting persons beneficially hold 9,583,333 Class B Ordinary Shares, representing 25.0% of the company's ordinary shares. These Class B shares are convertible into Class A Ordinary Shares on a one-for-one basis, subject to anti-dilution adjustments as described in the registration statement.
Based on the issuer's Form 10-K, the company had 38,333,333 ordinary shares outstanding as of March 16, 2026 (comprised of 28,750,000 Class A and 9,583,333 Class B). The filing discloses shared voting and dispositive power over the reported Class B shares by the Sponsor, Bleichroeder Manager 2 LLC, Andrew Gundlach, and Michel Combes, and notes 5,000,000 private placement warrants held by the Sponsor exercisable at $11.50 per share not exercisable within 60 days.